Jorge E. Lascano
Impact in
- Microbiology top 10%
-
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
Papers in
-
- Protease and Inhibitor Mechanisms 15
-
- Cystic Fibrosis Research Advances 8
- Inhalation and Respiratory Drug Delivery 2
- Co-authors
- E. Leonard Riley (12 shared papers)Jason Chertoff (2 shared papers)Mark Brantly (11 shared papers)Bryan A. Garcia (1 shared paper)Cesar Trillo‐Alvarez (5 shared papers)Giuseppe Morelli (3 shared papers)Fares Ayoub (3 shared papers)Michael Campos (8 shared papers)
- Journals
- ERJ Open Research (4 papers)Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (4 papers)QJM (3 papers)Respiratory Medicine (3 papers)Journal of Cystic Fibrosis (3 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Jorge E. Lascano
47 papers receiving 659 citations
Jorge E. Lascano's Hit Papers
Peers
Comparison fields: 5 of 86
- Microbiology 9
- Pulmonary and Respiratory Medicine 227
- Internal Medicine 21
- Critical Care and Intensive Care Medicine 25
- Cancer Research 68
Countries citing papers authored by Jorge E. Lascano
This map shows the geographic impact of Jorge E. Lascano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge E. Lascano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge E. Lascano more than expected).
Fields of papers citing papers by Jorge E. Lascano
This network shows the impact of papers produced by Jorge E. Lascano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge E. Lascano. The network helps show where Jorge E. Lascano may publish in the future.
Co-authors
The 25 scholars most cited alongside Jorge E. Lascano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study Hit paper breakdown → | 2023 | 109 |
| 2 | 2015 | 74 | |
| 3 | 2022 | 63 | |
| 4 | 2021 | 41 | |
| 5 | 2021 | 37 | |
| 6 | 2018 | 33 | |
| 7 | 2019 | 29 | |
| 8 | 2016 | 26 | |
| 9 | 2021 | 26 | |
| 10 | 2017 | 23 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2022 | 13 | |
| 15 | 2021 | 12 | |
| 16 | 2014 | 12 | |
| 17 | 2020 | 10 | |
| 18 | 2017 | 10 | |
| 19 | 2016 | 9 | |
| 20 | 2020 | 9 |
About Jorge E. Lascano
Jorge E. Lascano is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases and Critical Care and Intensive Care Medicine, having authored 48 papers that have together received 682 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (15 papers), Cystic Fibrosis Research Advances (8 papers), COVID-19 Clinical Research Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Long-Term Effects of COVID-19 (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Microbiology (9 citations), Pulmonary and Respiratory Medicine (227 citations), Internal Medicine (21 citations), Critical Care and Intensive Care Medicine (25 citations) and Cancer Research (68 citations). Jorge E. Lascano has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include E. Leonard Riley, Jason Chertoff, Mark Brantly, Bryan A. Garcia, Cesar Trillo‐Alvarez, Giuseppe Morelli, Fares Ayoub, Michael Campos, Lauryn A. Benninger and Nazli Khodayari. Their work appears in journals such as ERJ Open Research, Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, QJM, Respiratory Medicine and Journal of Cystic Fibrosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.